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A B S T R A C T  
Background: Postoperative pain creates complications by increasing circulating level of catecholamines and systemic vascular 
resistance, thus putting the patients on increased risks of having stroke and myocardial infarction. In addition, it increases hospital 
stay, causing burden over economic as well as healthcare infrastructure. The aim of this study was to determine the frequency of 
pain in the postoperative period while using Pregabalin as pre-medication among patients undergoing laparoscopic 
cholecystectomy. 
Material and Methods: The randomized control trail was conducted at Department of Anesthesiology, Holy Family hospital, 
Rawalpindi from 1st Sept 2015 to 28th Feb 2016 over a period of 6 months. A total of 200 patients undergoing laparoscopic 
cholecystectomy were randomly divided in group A and B by consecutive non-probability lottery method. Group A received 100 mg 
oral Pregabalin 1 hour before surgery and Group B were not given Pregabalin and were taken as controls. Post-operative pain was 
measured by visual analog scale (VAS) in terms of pain scores at 4 hours postoperatively after the arrival of patient in the post-
anesthesia care unit (PACU). SPSS version 17.0 was used to analyze the data. 
Results: A total of 200 patients were included in the study. There were 100 patients in each group. Based on the visual analog pain 
scores, 9 patients were pain free in group A compared with none in group B. Similarly, there were 55 patients in group A, who 
reported a pain score of 1 whereas no patient in group B had a VAS score of 1. There were 29 patients in group A and only 3 
patients in group B with VAS score of 2 (90.6% vs. 9.4%). For VAS score of 3, there were 6 patients in group A and 34 patients from 
group B (15% vs. 85%). For a VAS score of 4, there were 1 patient in group A and 61 patients in group B (1.6% vs. 98.4%). Two 
patients in group B experienced a VAS score of 5. All this data was significant with chi square p value of 0.0001. 
Conclusion: Oral Pregabalin administered prior to laparoscopic cholecystectomy was effective in reducing postoperative pain in 
the patients. Further studies are needed for post-operative evaluation of side effects, different dosing schedules at different time 
intervals for both rest and dynamic pain. 
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I n t r o d u c t i o n  
 
Pain is one of the commonest post-operative complaints 
all around the world after major surgical procedures.1 The 
post-operative pain control has a direct relationship with 
postoperative morbidity, reflecting its importance 
regarding time and adequate management.2 
Postoperative pain is involved in creating complications 
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by increasing circulating level of catecholamines and 
systemic vascular resistance, thus putting the patients at 
increased risks of having stroke and myocardial 
infarction.3 In addition, it increases hospital stay, which in 
turn cause burden over economic as well as healthcare 
infrastructure. The control of pain has been given less 
priority as reflected by number of health care programs 
conducted for pain education and its funding resources.4 
Early post-operative pain can decrease early ambulation, 
slows bowel function and be a major problem in early 
discharge of patients.5 Inadequate post-operative pain 
control may also lead to the development of chronic pain 
after surgery. Thus, attenuation of early post-operative 
pain remains an important concern for medical personal 
especially the anaesthtetist.5 
 
Pain after laparoscopic surgeries, especially laparoscopic 
cholecystectomy is a common complaint.6 Various 
analgesics have already been tried for the control of 
postoperative pain among these patients ranging from 
simple Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) 
to strong opioids, but none of them is specific and the 
adequate control of such pain is only possible with multi-
modal approach. Some recent studies have shown that 
use of Pregabalin as premedication can effectively control 
the postoperative pain and consumption of rescue 
analgesic medications after surgical procedure, and 
among patients undergoing general anesthesia for 
laparoscopic cholecystectomy.7,8  
 
A variety of post-operative anesthetic strategies ranging 
from simple analgesic agents administered orally to block 
nerve for pain management have been sought.9 A simpler 
strategy of preemptive analgesic agent may be more 
acceptable for both anesthetist and patients as a reliable 
pain relief technique.10 Preemptive analgesia is defined as 
an anti-nociceptive treatment that prevents establishment 
of altered central processing of afferent input from 
injuries.11 This can effectively prevent earlier onset of the 
pain than that of the preventive administration of the 
drugs after surgical procedures, but it was controversial 
whether preemptive or preventive analgesia should be 
used to describe the difference between the two analgesic 
techniques.12,13,14 
 
Gabapentene and its derivate Pregabalin had 
successfully been used in control of neuropathic pain in 
the past. Pregabalin is a GABAergic drug that acts on the 
GABA receptors at the level of spinal cord and brain to 
inhibit the pain signals.15 They bind to the pre-synaptic 
voltage gated calcium channels, thus causing reduction of 
calcium influx leading to reduction in release of various 
excitatory neurotransmitters. It has rapid extensive 
absorption after oral intake, 90% bioavailability with 
maximal plasma levels achieved after about 1 hour. The 
efficacy of Pregabalin has only been observed for limited 
procedures as in control of postoperative pain after 
laparoscopic hysterectomy orthopedic spinal fusion 
surgery and the dental procedures.16,17 The role of 
Pregabalin for Post-operative cholecystectomy has not 
yet been studied in detail especially in Pakistan, where 
cholelithiasis is an emerging issue because of change in 
life style and dietary habits. The purpose of this study was 
to evaluate the effectiveness of pre-operative analgesia 
using Pregabalin by measuring the frequency of post-
operative pain following laparoscopic cholecystectomy.  
 
M a t e r i a l  a n d  M e t h o d s  
This randomized control trial was conducted at 
Department of Anesthesiology, Holy Family hospital, 
Rawalpindi from 1st September 2015 to 28th February 
2016 over a period of 6 months. Approval from 
Institutional Ethics Committee was taken at the start of 
this study. After written informed consent, 200 patients of 
ages 20-40 years, categorized as American Society of 
Anesthesiologists I (ASA-I) (normal healthy patients) and 
ASA-II (mild systemic disease with no functional 
limitation) undergoing laparoscopic cholecystectomy were 
enrolled in the study. Exclusion criteria included patients 
with concomitant co-morbid conditions like diabetes 
mellitus, hypertension, malignancy, pulmonary, hepatic or 
renal diseases, patients with BMI >35, patients already 
taking Pregabalin, gabapenetene, opioid analgesic, long 
term NSAIDS/COX-2 inhibitors or other pain killers, or 
those patients in whom use of Pregabalin, Celecoxib or 
NSAIDS (due allergic/hypersensitivity reactions), or 
general anesthesia is contraindicated.  
 
All patients were assessed a day before surgery (at least 
8 hours before surgery as preoperative anesthesia fitness 
procedure). After overnight fasting, patients were 
randomly divided into group A and B by consecutive non-
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probability lottery method. Group A received 100 mg oral 
Pregabalin 1 hour before surgery and Group B were not 
given Pregabalin and were regarded as controls. 
Laproscopic cholecystectomy was performed according to 
the standard protocol. At the end of surgery, patients were 
extubated and shifted to the post-anesthesia care unit 
(PACU) for 24 hours monitoring, where the control of 
post-operative pain was strictly monitored. The pain score 
was measured at 4 hours postoperatively by the trainee 
researcher. 
 
The post-operative pain was assessed by using Visual 
Analog scale (VAS) graded no pain (0cm/0mm) to worst 
unbearable pain (10cm/100mm) (Figure1). Patients 
complaining of moderate to severe pain (pain score 5 or 
above) in either group at 4 hours or even before 
postoperatively were given rescue analgesic (Ketorolac 
30 mg slow intravenous injection), and the pain score was 
measured at that point. It was considered end point for 
that patient regardless of the fact that 4 hours have been 
passed and whatever the point score was present at that 
time. SPSS version 17 was used to analyze the data. 
Continuous variables like age, weight, height, BMI, 
duration of surgery and pain score at 4 hours were 
entered as mean + SD. Categorical variables like gender, 
pain score and pain category were analyzed as number 
and percentage. To compare the means, independent t-
test was applied. Chi-square and Fischer exact test were 
used to determine the association between categorical 
variables. P value < 0.05 was considered as statistically 
significant. 
 
Figure 1: Visual Analog scale for rating of pain intensity 
 
R e s u l t s  
A total of 200 patients were included in the study. There 
were 100 patients in each group. The baseline 
parameters of all study participants are given in Table I. 
Overall 198 (99%) patients complained of mild pain at 
4hrs post operatively whereas only 02 (1%) patients had 
moderate pain. There were no patients with severe post-
operative pain at 4hours. 
 
The baseline comparison of the two groups is given in 
Table II. Base line characteristics were same between two 
groups. The mean pain score was significantly high in 
group B at 4hrs post operatively. In group B, large number 
of patients had VAS score of 3 and 4 as compared to 
group A in which majority of patients had VAS score of 0, 
1 and 2. Regarding VAS pain category, in group B there 
was no patient with absence of post-operative pain while 
in group A, no patients presented with moderate or severe 
pain. Frequency of mild pain was approximately equal in 
both groups (Table III). 
 
Table I: baseline parameters of all study participants (n=200) 
Parameter Mean ± SD 
Age (years) 33.12 ± 4.095 
Weight (kg) 57.82 ± 10.865 
Height (m) 152.85 ± 10.293 
BMI (kg/m2) 24.67 ± 2.58 
Duration of Surgery (hours) 48.44 ± 5.47 
Pain Score at 4 hours 2.48 ± 1.32 
 No. of patients (Percentage) 
Gender Male 38 (19) 
Female 162 (81) 
Pain Score 0 09 (4.5) 
 1 55 (27.5) 
 2 32 (16.0) 
 3 40 (20.0) 
 4 62 (31.0) 
 5 02 (1.0) 
Pain 
Category 
No 09 (4.5) 
 Mild 189 (94.5) 
 Moderate 02 (1.0) 
 
Table II: Baseline comparison of the two groups (n=200) 
Gender n (%) Group A Group B P value 
 Males 23 (60.5) 15 (39.5) 0.15 
Females 77 (47.5) 85 (42.5) 
 Mean ± SD Mean ± SD 0.52 
Age (years) 32.93 ± 4.38 33.30 ± 3.80 
Weight (kg) 56.93 ± 11.53 58.72 ± 10.14 0.25 
Height (m) 1.53 ± 0.11 1.52 ± 0.09 0.80 
BMI (kg/m2) 24.32 ± 3.25 25.03 ± 1.62 0.52 
Duration of 
Surgery (min) 
48.53 ± 6.59 48.35 ± 4.09 0.82 
Pain Score at 
4hrs 
1.35 ± 0.77 3.62 ± 0.58 0.0001 
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Table III: Comparison of different Visual Analog Scores (n=200) 






0 9 (100) 0 
1 55 (100) 0 
2 29 (90.6) 03 (9.4) 
3 06 (15) 34 (85) 
4 01 (1.6) 61 (98.4) 
5 0 02 (100) 
Chi square: p= 0.0001 






No pain 9 (100%) 0 
Mild 91 (48.1%) 98 (51.9%) 
Moderate 0 02 (100%) 
Severe 0 0 
Chi square p value 0.004 
 
D i s c u s s i o n  
Pain is thought to be inadequately treated in one-half of 
all surgical procedures. Early postoperative pain is the 
most common complaint after elective laparoscopic 
cholecystectomy.18 Our study participants experienced 
post-operative pain at 4hrs after laparoscopic 
cholecystectomy in more than 90% cases. The 
corresponding pain categories were mild in 9 (4.5%) and 
moderate in 189 (94.5%) patients.  No patients reported 
severe post-operative pain. Pain is the main reason for 
overnight hospital stay up to 40% patients after day care 
surgery. Postoperative pain is the main reason for 
delayed recovery after laparoscopic cholecystectomy and 
major factor for development of “post-laparoscopic 
cholecystectomy syndrome”.19  
 
In recent years, pregabalin has been introduced as an 
adjunct in the multimodal management of postoperative 
analgesia.20 According to a meta-analysis, the analgesic 
effect of pregabalin is best experienced in early 
postoperative period.21 Numerous studies have evaluated 
the efficacy and adverse effects of pregabalin in reducing 
acute postoperative pain.21, 22. In our study, Pregablin was 
found to be an effective drug for post-operative analgesia 
with 9 (9%) patients experiencing no pain and 91 (91%) 
had mild pain in the pregabalin group. Our findings are 
congruent with Agarwal and co-workers who also proved 
that single pre-operative dose of Pregabalin can 
effectively control the post-operative pain among patients 
undergoing laparoscopic cholecystectomy. 8 
 
Evidence also shows that other surgical procedures 
where pregabalin was administered preoperatively had a 
clear reduction in post-operative pain. In a recently 
published article, it was seen that pregabalin use at least 
one hour prior to Septoplasty reduced post-operative pain 
significantly, although the required dosage and 
associated adverse effects need further scientific 
probing.23 According to a set of recent guidelines 
published by The American Pain society and based on an 
extensive review of literature, it was suggested that 
optimal postoperative pain management begins in the 
preoperative period. This observation is made on the 
basis of an assessment of the patient and development of 
a plan of care tailored to the individual and the surgical 
procedure involved, with follow-up assessments and 
adjustments as needed. 24 
 
C o n c l u s i o n  
Oral pregabalin administered preoperatively, was effective 
in reducing postoperative pain in patients undergoing 
laparoscopic cholecystectomy. It can also be concluded 
that the journey towards good pain control after surgery 
starts before the actual procedure is initiated. Further 
studies are needed for post-operative evaluation of side 
effects, different dosing schedules at different time 
intervals for both rest and dynamic pain.  
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